Cargando…
Size of HIV‐1 reservoir is associated with telomere shortening and immunosenescence in early‐treated European children with perinatally acquired HIV‐1
INTRODUCTION: Persistence of HIV‐1, causing chronic immune activation, is a key determinant of premature senescence. Early antiretroviral therapy (ART) has been associated with a reduced HIV‐1 reservoir in children with perinatally acquired HIV‐1 (PHIV), but its impact on the senescence process is a...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604380/ https://www.ncbi.nlm.nih.gov/pubmed/34797948 http://dx.doi.org/10.1002/jia2.25847 |
_version_ | 1784601948203253760 |
---|---|
author | Dalzini, Annalisa Ballin, Giovanni Dominguez‐Rodriguez, Sara Rojo, Pablo Petrara, Maria Raffaella Foster, Caroline Cotugno, Nicola Ruggiero, Alessandra Nastouli, Eleni Klein, Nigel Rinaldi, Stefano Pahwa, Savita Rossi, Paolo Giaquinto, Carlo Palma, Paolo De Rossi, Anita |
author_facet | Dalzini, Annalisa Ballin, Giovanni Dominguez‐Rodriguez, Sara Rojo, Pablo Petrara, Maria Raffaella Foster, Caroline Cotugno, Nicola Ruggiero, Alessandra Nastouli, Eleni Klein, Nigel Rinaldi, Stefano Pahwa, Savita Rossi, Paolo Giaquinto, Carlo Palma, Paolo De Rossi, Anita |
author_sort | Dalzini, Annalisa |
collection | PubMed |
description | INTRODUCTION: Persistence of HIV‐1, causing chronic immune activation, is a key determinant of premature senescence. Early antiretroviral therapy (ART) has been associated with a reduced HIV‐1 reservoir in children with perinatally acquired HIV‐1 (PHIV), but its impact on the senescence process is an open question. We investigated the association between HIV‐1 reservoir and biological and immune ageing profile in PHIV enrolled in the multicentre cross‐sectional study CARMA (Child and Adolescent Reservoir Measurements on early suppressive ART) conducted within the EPIICAL (Early treated Perinatally HIV Infected individuals: Improving Children's Actual Life) consortium. METHODS: Between September 2017 and June 2018, CARMA enrolled 40 PHIV who started ART before 2 years of age and had undetectable viremia for at least 5 years before sampling date. Samples from 37 children with a median age of 13.8 years were available for this study. HIV‐1 DNA copies on CD4 cells, relative telomere length (marker of cellular senescence) and levels of T‐cell receptor rearrangement excision circle (TREC, marker of thymic output) on CD4 and CD8 cells were quantified by qPCR. Immunological profile was assessed by flow cytometry. Associations between molecular and phenotypic markers, HIV‐1 reservoir and age at ART initiation were explored using a multivariable Poisson regression. RESULTS: Higher HIV‐1 reservoir was associated (p<0.001) with telomere shortening (incidence rate ratio [IRR] = 0.15 [0.13–0.17]), immunosenescence (CD28(–)CD57(+), IRR = 1.23 [1.21–1.26]) and immunoactivation (CD38(+) HLADR(+), IRR = 7.29 [6.58–8.09]) of CD4 cells. Late ART initiation (after 6 months of age) correlated with higher HIV‐1 reservoir levels (552 [303–1001] vs. 89 [56–365] copies/10(6) CD4 cells, p = 0.003) and percentage of CD4 senescent cells (2.89 [1.95–6.31] vs. 1.02 [0.45–2.69, p = 0.047). TREC levels in CD8 cells were inversely associated with HIV‐1 reservoir (IRR = 0.77 [0.76–0.79]) and were significantly lower in late treated PHIV (1128 [486–1671] vs. 2278 [1425–3314], p = 0.042). CONCLUSIONS: Later ART initiation is associated with higher HIV‐1 reservoir size, which correlates with increased telomere shortening and senescence of CD4 cells. Timing of ART initiation in infancy has long‐term consequences on the immune and biological ageing profile of children with perinatally acquired HIV‐1. |
format | Online Article Text |
id | pubmed-8604380 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86043802021-11-24 Size of HIV‐1 reservoir is associated with telomere shortening and immunosenescence in early‐treated European children with perinatally acquired HIV‐1 Dalzini, Annalisa Ballin, Giovanni Dominguez‐Rodriguez, Sara Rojo, Pablo Petrara, Maria Raffaella Foster, Caroline Cotugno, Nicola Ruggiero, Alessandra Nastouli, Eleni Klein, Nigel Rinaldi, Stefano Pahwa, Savita Rossi, Paolo Giaquinto, Carlo Palma, Paolo De Rossi, Anita J Int AIDS Soc Research Articles INTRODUCTION: Persistence of HIV‐1, causing chronic immune activation, is a key determinant of premature senescence. Early antiretroviral therapy (ART) has been associated with a reduced HIV‐1 reservoir in children with perinatally acquired HIV‐1 (PHIV), but its impact on the senescence process is an open question. We investigated the association between HIV‐1 reservoir and biological and immune ageing profile in PHIV enrolled in the multicentre cross‐sectional study CARMA (Child and Adolescent Reservoir Measurements on early suppressive ART) conducted within the EPIICAL (Early treated Perinatally HIV Infected individuals: Improving Children's Actual Life) consortium. METHODS: Between September 2017 and June 2018, CARMA enrolled 40 PHIV who started ART before 2 years of age and had undetectable viremia for at least 5 years before sampling date. Samples from 37 children with a median age of 13.8 years were available for this study. HIV‐1 DNA copies on CD4 cells, relative telomere length (marker of cellular senescence) and levels of T‐cell receptor rearrangement excision circle (TREC, marker of thymic output) on CD4 and CD8 cells were quantified by qPCR. Immunological profile was assessed by flow cytometry. Associations between molecular and phenotypic markers, HIV‐1 reservoir and age at ART initiation were explored using a multivariable Poisson regression. RESULTS: Higher HIV‐1 reservoir was associated (p<0.001) with telomere shortening (incidence rate ratio [IRR] = 0.15 [0.13–0.17]), immunosenescence (CD28(–)CD57(+), IRR = 1.23 [1.21–1.26]) and immunoactivation (CD38(+) HLADR(+), IRR = 7.29 [6.58–8.09]) of CD4 cells. Late ART initiation (after 6 months of age) correlated with higher HIV‐1 reservoir levels (552 [303–1001] vs. 89 [56–365] copies/10(6) CD4 cells, p = 0.003) and percentage of CD4 senescent cells (2.89 [1.95–6.31] vs. 1.02 [0.45–2.69, p = 0.047). TREC levels in CD8 cells were inversely associated with HIV‐1 reservoir (IRR = 0.77 [0.76–0.79]) and were significantly lower in late treated PHIV (1128 [486–1671] vs. 2278 [1425–3314], p = 0.042). CONCLUSIONS: Later ART initiation is associated with higher HIV‐1 reservoir size, which correlates with increased telomere shortening and senescence of CD4 cells. Timing of ART initiation in infancy has long‐term consequences on the immune and biological ageing profile of children with perinatally acquired HIV‐1. John Wiley and Sons Inc. 2021-11-19 /pmc/articles/PMC8604380/ /pubmed/34797948 http://dx.doi.org/10.1002/jia2.25847 Text en © 2021 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Dalzini, Annalisa Ballin, Giovanni Dominguez‐Rodriguez, Sara Rojo, Pablo Petrara, Maria Raffaella Foster, Caroline Cotugno, Nicola Ruggiero, Alessandra Nastouli, Eleni Klein, Nigel Rinaldi, Stefano Pahwa, Savita Rossi, Paolo Giaquinto, Carlo Palma, Paolo De Rossi, Anita Size of HIV‐1 reservoir is associated with telomere shortening and immunosenescence in early‐treated European children with perinatally acquired HIV‐1 |
title | Size of HIV‐1 reservoir is associated with telomere shortening and immunosenescence in early‐treated European children with perinatally acquired HIV‐1 |
title_full | Size of HIV‐1 reservoir is associated with telomere shortening and immunosenescence in early‐treated European children with perinatally acquired HIV‐1 |
title_fullStr | Size of HIV‐1 reservoir is associated with telomere shortening and immunosenescence in early‐treated European children with perinatally acquired HIV‐1 |
title_full_unstemmed | Size of HIV‐1 reservoir is associated with telomere shortening and immunosenescence in early‐treated European children with perinatally acquired HIV‐1 |
title_short | Size of HIV‐1 reservoir is associated with telomere shortening and immunosenescence in early‐treated European children with perinatally acquired HIV‐1 |
title_sort | size of hiv‐1 reservoir is associated with telomere shortening and immunosenescence in early‐treated european children with perinatally acquired hiv‐1 |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604380/ https://www.ncbi.nlm.nih.gov/pubmed/34797948 http://dx.doi.org/10.1002/jia2.25847 |
work_keys_str_mv | AT dalziniannalisa sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1 AT ballingiovanni sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1 AT dominguezrodriguezsara sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1 AT rojopablo sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1 AT petraramariaraffaella sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1 AT fostercaroline sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1 AT cotugnonicola sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1 AT ruggieroalessandra sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1 AT nastoulieleni sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1 AT kleinnigel sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1 AT rinaldistefano sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1 AT pahwasavita sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1 AT rossipaolo sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1 AT giaquintocarlo sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1 AT palmapaolo sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1 AT derossianita sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1 AT sizeofhiv1reservoirisassociatedwithtelomereshorteningandimmunosenescenceinearlytreatedeuropeanchildrenwithperinatallyacquiredhiv1 |